M
Mark H. Einstein
Researcher at Rutgers University
Publications - 175
Citations - 10365
Mark H. Einstein is an academic researcher from Rutgers University. The author has contributed to research in topics: Cervical cancer & Cancer. The author has an hindex of 44, co-authored 163 publications receiving 8603 citations. Previous affiliations of Mark H. Einstein include Yeshiva University & University of Alabama at Birmingham.
Papers
More filters
Journal ArticleDOI
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors
L. Stewart Massad,Mark H. Einstein,Warner K. Huh,Hormuzd A. Katki,Walter Kinney,Mark Schiffman,Diane Solomon,Nicolas Wentzensen,Herschel W. Lawson +8 more
TL;DR: The group’s goal was to provide revised evidence-based consensus guidelines for managing women with abnormal cervical cancer screening tests, cervical intraepithelial neoplasia (CIN) and adenocarcinoma in situ (AIS) following adoption of cervical cancer screenings guidelines incorporating longer screening intervals and co-testing.
Journal ArticleDOI
Human papillomavirus and cervical cancer.
TL;DR: More sensitive than cytology, primary screening by human papillomavirus testing could enable screening intervals to be extended and if these prevention strategies can be implemented in developing countries, many thousands of lives could be saved.
Journal ArticleDOI
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Rebecca B. Perkins,Richard S. Guido,Philip E. Castle,David Chelmow,Mark H. Einstein,Francisco A.R. Garcia,Warner K. Huh,Jane J. Kim,Anna-Barbara Moscicki,Ritu Nayar,Mona Saraiya,George F. Sawaya,Nicolas Wentzensen,Mark Schiffman +13 more
TL;DR: The 2019 ASCCP Risk-Based Management Consensus Guidelines Committee concluded that the current consensus on risk-based management guidelines is inadequate and called for further work on this issue.
Journal ArticleDOI
American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors
Debbie Saslow,Philip E. Castle,J. Thomas Cox,Diane D. Davey,Mark H. Einstein,Daron G. Ferris,Sue J. Goldie,Diane M. Harper,Walter Kinney,Walter Kinney,Anna-Barbara Moscicki,Kenneth L. Noller,Cosette M. Wheeler,Terri Ades,Kimberly S. Andrews,Mary Doroshenk,Kelly Green Kahn,C. J. Schmidt,Omar Shafey,Robert A. Smith,Edward E. Partridge,Francisco A.R. Garcia +21 more
TL;DR: Recommendations on the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues, and implications for screening are discussed.
Journal ArticleDOI
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors
L. Stewart Massad,Mark H. Einstein,Warner K. Huh,Hormuzd A. Katki,Walter Kinney,Mark Schiffman,Diane Solomon,Nicolas Wentzensen,Herschel W. Lawson +8 more
TL;DR: A group of 47 experts representing 23 professional societies, national and international health organizations, and federal agencies met in Bethesda, MD, September 14-15, 2012, to revise the 2006 American Society for Colposcopy and Cervical Pathology Consensus Guidelines as discussed by the authors.